Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

973
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
973
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

1.0K
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.0K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

826
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Expanding Role of Artificial Intelligence in Companion Animal Care: A Systematic Review.

Animals : an open access journal from MDPI·2026
Same author

Intracardiac Echocardiography during Invasive Electrophysiological Procedures: a Scientific Statement of the European Heart Rhythm Association of the ESC, and the European Association of Percutaneous Cardiovascular Interventions of the ESC.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Time to rethink ICD indications in non-ishaemic cardiomyopathy? Evidence from a meta-analysis across therapeutic eras.

ESC heart failure·2026
Same author

Durability of Exercise vs. Revascularization in Intermittent Claudication: An Updated Meta-Analysis of Randomized Trials Focusing on Patient-Centered Outcomes.

Healthcare (Basel, Switzerland)·2026
Same author

Machine Learning-Based Risk Stratification for Sudden Cardiac Death Using Clinical and Device-Derived Data.

Sensors (Basel, Switzerland)·2026
Same author

Completely Fluoroless, "Apron-Less" Approach to Supraventricular Tachycardia Ablation Compared to Traditional Fluoroscopy Guided Ablation: Feasibility, Safety and Clinical Outcomes.

Journal of clinical medicine·2025

Related Experiment Video

Updated: May 5, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Improving Risk Stratification in Sudden Cardiac Death Using Interpretable Machine Learning: A Clinical Perspective.

Hana Ivandic1, Branimir Pervan1, Vedran Velagic2,3

  • 1Faculty of Electrical Engineering and Computing, University of Zagreb, Unska 3, 10000 Zagreb, Croatia.

Healthcare (Basel, Switzerland)
|November 13, 2025
PubMed
Summary

Machine learning improves sudden cardiac death (SCD) risk prediction for implantable cardioverter-defibrillator (ICD) selection. This approach refines patient stratification beyond traditional metrics, enhancing protection for those at risk.

Keywords:
implantable cardioverter-defibrillatorinterpretabilitylogistic regressionmachine learningsudden cardiac death

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

Related Experiment Videos

Last Updated: May 5, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

Area of Science:

  • Cardiology
  • Medical Informatics
  • Machine Learning

Background:

  • Sudden cardiac death (SCD) is a significant cause of cardiovascular mortality.
  • Current implantable cardioverter-defibrillator (ICD) selection lacks precision, leading to suboptimal patient outcomes.
  • Interpretable machine learning (ML) offers a potential solution for improved risk stratification.

Purpose of the Study:

  • To develop and validate an interpretable ML model for predicting appropriate ICD activation.
  • To refine patient selection for ICD implantation using diverse clinical data.
  • To enhance the transparency of clinical reasoning in SCD risk assessment.

Main Methods:

  • Retrospective analysis of 607 patients undergoing ICD or CRT-D implantation.
  • Collection of comprehensive baseline data: demographic, clinical, echocardiographic, laboratory, and device-related variables.
  • Development of a logistic regression (LR) model to predict appropriate ICD activation, using patient follow-up data.

Main Results:

  • The LR model achieved strong predictive performance (AUC-ROC 0.74, sensitivity 86.50%).
  • Key predictors identified include ventricular tachycardia (VT) burden, sustained VT, longer follow-up, and secondary prevention.
  • Combination therapy with furosemide and spironolactone was associated with lower predicted SCD risk.

Conclusions:

  • ML applied to routine clinical data can significantly enhance SCD risk stratification.
  • This approach complements existing guideline criteria by confirming known predictors and identifying novel associations.
  • Interpretable ML models can support clinical decision-making for ICD implantation, improving patient selection and outcomes.